BASELINE 89ZR-RITUXIMAB PET MAY PREDICT THERAPEUTIC RESPONSE 24 WEEKS AFTER INITIATION OF RITUXIMAB TREATMENT IN RHEUMATOID ARTHRITIS PATIENTS

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)159-159
JournalAnnals of the Rheumatic Diseases
Volume75
DOIs
Publication statusPublished - Jun 2016

Cite this